1. United States of America Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Procter & Gamble Company

Procter & Gamble Company

PRG.DE
Procter & Gamble CompanyDE flagDeutsche Börse
128.94
EUR
-2.60
- -
300.25BMarket Cap
Procter & Gamble Company
PRG.DE
(Deutsche Börse)

Recent

price

128.94

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
26.31
28.92
29.12
28.61
26.77
25.14
23.61
24.62
26.42
25.18
27.94
30.27
32.64
33.97
34.91
35.19
36.47
Revenue per Share
4.25
4.12
3.73
3.95
4.1
2.41
3.71
5.71
3.75
1.35
5.03
5.58
5.89
5.95
6.06
6.55
6.86
Basic EPS, GAAP
5.47
4.75
4.72
5.31
5.02
5.19
5.58
4.83
5.88
5.67
6.85
7.31
6.81
6.98
8.24
7.44
8.16
Free Cash Flow per Basic Share
1.85
2.06
2.18
2.33
2.49
2.59
2.69
2.74
2.89
2.79
3.07
3.29
3.57
3.73
3.87
4.12
4.28
Dividend per Share
23.28
26.64
28.18
30.07
32.03
31.56
33.26
37.89
40.58
36.81
41.05
43.9
47.39
50.61
53.09
55.94
58.64
Book Value per Share
-8.64
-8.35
-7.79
-6.85
-5.64
-2.72
-4.31
-5.34
-6.78
-6.64
-6.97
-7.47
-7.07
-7.54
-5.23
-5.03
-3.75
Tangible Book Value per Share
2,948
2,804
2,816
2,800
2,779
2,814
2,765
2,642
2,529
2,688
2,539
2,514
2,457
2,414
2,408
2,395
2,378
Basic Weighted Avg Shares
77,567
81,104
82,006
80,116
74,401
70,749
65,299
65,058
66,832
67,684
70,950
76,118
80,187
82,006
84,039
84,284
86,718
Sales/Revenue/Turnover
20.28
19.11
17.82
17.63
18.7
18.48
20.58
21.16
19.99
20.44
22.14
23.63
22.21
22.11
23.66
24.26
23.24
Operating Margin (%)
3,108
2,838
3,204
2,982
3,141
3,134
3,078
2,820
2,834
2,824
3,013
2,735
2,807
2,714
2,896
2,847
3,071
Depreciation Expense
12,736
11,797
10,756
11,312
11,643
7,036
10,508
15,326
9,750
3,897
13,027
14,306
14,742
14,653
14,879
15,974
16,616
Net Income, GAAP
27.02
22
26.96
22.75
21.1
24.75
25
23.1
26
34.65
17.25
18.52
17.79
19.7
20.19
20.34
20.4
Effective Tax Rate (%)
16.42
14.55
13.12
14.12
15.65
9.95
16.09
23.56
14.59
5.76
18.36
18.79
18.38
17.87
17.7
18.95
19.16
Profit Margin (%)
-5,500
-5,323
-2,997
-6,047
-2,109
-144
3,012
-3,716
-4,917
-7,538
-4,989
-10,041
-11,428
-13,108
-8,918
-10,666
-10,248
Working Capital
21,360
22,033
21,080
19,111
19,811
18,327
18,945
18,038
20,863
20,395
24,189
23,730
23,443
24,973
25,935
25,696
23,852
LT Debt
61,439
68,001
64,035
68,709
69,976
63,050
57,983
55,778
52,883
47,579
46,878
46,654
46,854
47,065
50,558
52,284
54,731
Total Equity
11.98
12.59
10.94
11.17
10.59
9.82
11
11.97
11.48
11.13
16.13
17.95
18.32
17.86
18.86
18.74
17.98
Return on Invested Capital (%)
13.32
11.82
10.19
10.28
9.89
5.99
8.85
12.11
7.45
3.13
9.83
10.28
10.23
9.84
9.67
9.98
9.97
Return on Capital (%)
19.27
16.14
13.63
13.53
13.15
7.62
11.34
15.7
9.35
3.61
12.56
13.08
12.75
12.05
11.68
11.98
11.99
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
11,631
11,062
13,174
LT Borrowings
24,315
25,577
23,852
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
770
767
759
Shares Outstanding
2,337
2,324
2,329
Market Capitalization
367,872
344,352
341,123

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
27,118
26,588
27,987
Cash, Cash Equivalents & STI
11,171
10,825
12,306
Accounts Receivable, Net
6,487
6,279
6,322
Inventories
7,848
7,817
7,853
Total Current Liabilities
37,995
36,699
38,235
Payables & Accruals
26,365
25,636
25,061
ST Debt
11,631
11,062
13,174
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.73%
2.25%
3.41%
Free Cash Flow
2.65%
0.98%
-10.22%
Net Income, GAAP
25.42%
4.23%
7.36%
Sales/Revenue/Turnover
1.84%
3.53%
0.29%
Total Cash Common Dividend
3.18%
4.96%
6.13%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
21,871
21,441
20,195
20,532
84,039
2025
21,737
21,882
19,776
20,889
84,284
2026
22,386
22,208
21,235
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.89
1.41
1.56
1.27
6.06
2025
1.62
1.91
1.55
1.48
6.55
2026
1.97
1.79
1.63
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.97
0.95
0.97
1.01
3.87
2025
1.02
1.02
1.02
1.07
4.12
2026
1.07
1.07
1.07
- -
- -
Similar Companies
Cosmax, Inc. (192820.KS)
European Wax Center, Inc. (EWCZ)
Oliveda International, Inc. (OLVI)
PT Victoria Care Indonesia Tbk (VICI.JK)
Essity AB (publ) (ESSITY-B.ST)
Colgate-Palmolive (India) Limited (COLPAL.BO)
Business
The Procter & Gamble Company (P&G) manufactures and markets a broad portfolio of branded consumer goods focused on beauty, grooming, health care, fabric and home care, and baby and family care products worldwide. The company offers baby diapers and related products under the Pampers, Luvs, and Ninjamas brands; laundry detergents and fabric care items including Tide, Ariel, Gain, Downy, Bounce, Dreft, Era, and Cheer; paper towels, toilet paper, and tissues via Bounty, Charmin, and Puffs; feminine care solutions such as Always, Always Discreet, Tampax, Just, and This is L; grooming products encompassing razors, blades, and skin care from Gillette, Gillette Venus, Braun, joy+glee, and The Art of Shaving; hair care lines like Pantene, Head & Shoulders, Aussie, Herbal Essences, Old Spice, My Black Is Beautiful, and Gemz; home care brands including Dawn, Cascade, Febreze, Mr. Clean, Swiffer, Gain, Microban 24, Salvo, Ambi Pur, and Zevo; oral care offerings from Crest, Oral-B, Fixodent, and Scope; personal health care products such as Vicks, Pepto-Bismol, Prilosec OTC, Align, Metamucil, ZzzQuil, and Clearblue; and skin and personal care items under Olay, Secret, Safeguard, Ivory, Native, and SK-II. Founded in 1837 and headquartered in Cincinnati, Ohio, P&G operates in more than 180 countries, serving consumers through retail channels with an emphasis on innovation, sustainability, and superior performance. Recent developments include a US$150 million expansion of its Iowa City, Iowa facility to enhance Oral-B production capacity starting in 2027, adding 100 jobs and marking a significant onshoring of manufacturing; an ongoing large-scale restructuring initiative targeting up to 7,000 non-manufacturing role reductions by mid-2027 to fund innovation and portfolio simplification, alongside evaluations of potential brand divestitures in underperforming categories; new product launches such as Pampers Swaddlers Pxxs for preterm infants, Always Pocket Flexfoam for period protection, and Gemz water-activated haircare; and sustained organic sales growth of 2% with core EPS up 3% in fiscal 2026's first quarter, supported by innovations in Tide and Pampers amid competitive pressures.